AIDS

Home Current Issue Previous Issues Published Ahead-of-Print Collections For Authors Journal Info

October 14, 2005 - Volume 19 - Issue 15 - Contributor Index

View All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Select All | Hide Details
Previous Page of 12 Next
Author Name Article
Abadi, Jacob

Partial treatment interruption of protease inhibitors augments HIV-specific immune responses in vertically infected pediatric patients

AIDS. 19(15):1575-1585, October 14, 2005.

Free Access
+ My Favorites
PDF (496 KB)
Show Abstract
Adda, Nathalie

Short-term safety and pharmacodynamics of amdoxovir in HIV-infected patients

AIDS. 19(15):1607-1615, October 14, 2005.

Free Access
+ My Favorites
PDF (2.61 MB)
Show Abstract
Adegbola, Richard A

Mycobacterium africanum: a new opportunistic pathogen in HIV infection?

AIDS. 19(15):1714-1715, October 14, 2005.

Free Access
+ My Favorites
PDF (792 KB)
Agarwala, Sangeeta

Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction

AIDS. 19(15):1635-1641, October 14, 2005.

Free Access
+ My Favorites
PDF (120 KB)
Show Abstract
Aït-Mohand, Hocine

No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patients

AIDS. 19(15):1643-1647, October 14, 2005.

Free Access
+ My Favorites
PDF (117 KB)
Show Abstract
Aldrovandi, Grace M

Prolonged breast-feeding and mortality up to two years post-partum among HIV-positive women in Zambia

AIDS. 19(15):1677-1681, October 14, 2005.

Free Access
+ My Favorites
PDF (89 KB)
Show Abstract
Andrews, Laurie

Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction

AIDS. 19(15):1635-1641, October 14, 2005.

Free Access
+ My Favorites
PDF (120 KB)
Show Abstract
Antinori, Andrea

Structured treatment interruption in HIV-infected patients failing on multidrug therapy: is there a future for this strategy?

AIDS. 19(15):1691-1694, October 14, 2005.

Free Access
+ My Favorites
PDF (69 KB)
Ariën, Kevin K

Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time

AIDS. 19(15):1555-1564, October 14, 2005.

Free Access
+ My Favorites
PDF (1.07 MB)
Show Abstract
Arts, Eric J

Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time

AIDS. 19(15):1555-1564, October 14, 2005.

Free Access
+ My Favorites
PDF (1.07 MB)
Show Abstract
Barcellos, Nêmora T

Response to 'Impact of antiretroviral treatment on progression of hepatic fibrosis in HIV/hepatitis C virus co-infected patients' by Marine-Barjoan et al

AIDS. 19(15):1707, October 14, 2005.

Free Access
+ My Favorites
PDF (792 KB)
Barin, Francis

Impact of AIDS on adult mortality: a morgue-based study in Pointe-Noire, Republic of Congo

AIDS. 19(15):1683-1687, October 14, 2005.

Free Access
+ My Favorites
PDF (79 KB)
Show Abstract
Barjoan, Eugenia Mariné

Response to comments of Paul et al

AIDS. 19(15):1707-1708, October 14, 2005.

Free Access
+ My Favorites
PDF (792 KB)
Barrow, Peter H

HIV and achalasia

AIDS. 19(15):1709-1711, October 14, 2005.

Free Access
+ My Favorites
PDF (792 KB)
Baty, Gaelle

Impact of AIDS on adult mortality: a morgue-based study in Pointe-Noire, Republic of Congo

AIDS. 19(15):1683-1687, October 14, 2005.

Free Access
+ My Favorites
PDF (79 KB)
Show Abstract
Becquet, Renaud

HIV and infant feeding: a complex issue in resource-limited settings

AIDS. 19(15):1717-1718, October 14, 2005.

Free Access
+ My Favorites
PDF (792 KB)
Bedini, Andrea

Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study

AIDS. 19(15):1627-1633, October 14, 2005.

Free Access
+ My Favorites
PDF (133 KB)
Show Abstract
Biglia, Alejandra

High rate of virological failure in maintenance antiretroviral therapy with didanosine and tenofovir

AIDS. 19(15):1695-1697, October 14, 2005.

Free Access
+ My Favorites
PDF (189 KB)
Show Abstract
Blanchard, James

Cellulose acetate 1,2-benzenedicarboxylate protects against challenge with pathogenic X4 and R5 simian/human immunodeficiency virus

AIDS. 19(15):1587-1594, October 14, 2005.

Free Access
+ My Favorites
PDF (189 KB)
Show Abstract

Safety and distribution of cellulose acetate 1,2-benzenedicarboxylate (CAP), a candidate anti-HIV microbicide in rhesus macaques

AIDS. 19(15):1595-1599, October 14, 2005.

Free Access
+ My Favorites
PDF (14.32 MB)
Show Abstract
Select All
Previous Page of 12 Next